Another type of small-molecule, Bax agonist, also induces conformational alteration in Bax protein by blocking serine 184 phosphorylation, enhancing the formation of Bax oligomers to become the channels at mitochondrial outer membrane leading to cytochrome c release and apoptosis induction in human lung cancer cells [39]. Here, CYCS is linked to lung carcinoma.